Eton Pharmaceuticals, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Fund move
Fund move
Last report2 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
+44.26%
vs ±10.6% implied · ×4.19
shaded = implied · ▲▼ = realized
No thesis.
Eton Pharmaceuticals, Inc.
52.20
−1.47 · −2.75%
post 52.20 +0.01%
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Opaleye ManagementOpaleye | $103.5M | 14.18% | 0.00% | |
| 2 | EcoR1 CapitalEcoR1 Capital | $78.6M | 10.77% | 0.00% | |
| 3 | BlackRockBlackRockindex-like | $68.6M | 9.40% | +10.40% | |
| 4 | Nantahala Capital ManagementNantahala | $42.6M | 5.83% | 0.00% | |
| 5 | Vanguard Capital ManagementVanguardindex-like | $35.4M | 4.84% | −1.76% | |
| 6 | Morgan StanleyMorgan Stanley | $27.8M | 3.81% | +60.68% | |
| 7 | State StreetState Streetindex-like | $25.4M | 3.48% | +32.36% | |
| 8 | Geode Capital ManagementGeodeindex-like | $23.6M | 3.23% | +12.92% | |
| 9 | Oberweis Asset Management Inc/Oberweis Asset Management Inc/ | $18.2M | 2.49% | +14.18% | |
| 10 | National Philanthropic TrustNational Philanthropic Trust | $17.8M | 2.44% | 0.00% | |
| 11 | Westside Investment ManagementWestside | $15.6M | 2.14% | −7.86% | |
| 12 | Pillsbury Lake CapitalPillsbury Lake Capital | $14.0M | 1.92% | +6.08% | |
| 13 | NuveenNuveenindex-like | $13.6M | 1.86% | +548.33% | |
| 14 | BNP Paribas ArbitrageBNP Paribas Arbitrage | $11.7M | 1.60% | +6.74% | |
| 15 | Woodline PartnersWoodline Partners | $11.3M | 1.54% | +82.12% | |
| 16 | Thompson Siegel & WalmsleyThompson Siegel & Walmsley | $10.8M | 1.47% | −26.81% | |
| 17 | Northern TrustNorthern Trustindex-like | $9.3M | 1.27% | +7.58% | |
| 18 | Marshall WaceMarshall Wace | $9.0M | 1.24% | +201.23% | |
| 19 | Jane Street GroupJane Street | $8.0M | 1.09% | +64.69% | |
| 20 | Panoramic CapitalPanoramic Capital | $7.5M | 1.03% | +12.54% | |
| 21 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $7.0M | 0.96% | +28.23% | |
| 22 | JPMorgan ChaseJPMorgan Chase | $7.0M | 0.96% | +12.81% | |
| 23 | D. E. ShawD. E. Shaw | $6.8M | 0.93% | new | |
| 24 | Lumbard & KellnerLumbard & Kellner | $6.4M | 0.87% | 0.00% | |
| 25 | Cannell CapitalCannell Capital | $6.2M | 0.85% | −50.07% |
164 managers report $730.2M of Eton Pharmaceuticals on form 13F for the quarter ended Jun 30 '26. 25 of them hold 80% of it; Opaleye is largest at 14.18%.
Expected move
Inputs8Q avg ±12.1%·×0.77·cheap
straddle ±14.7%
spot 52.18exp Nov 20ATM strike 50ATM straddle 9.02IV 88%